Unknown

Dataset Information

0

Purine-scaffold Hsp90 inhibitors.

ABSTRACT: Hsp90 is a molecular chaperone with important roles in regulating the function of several proteins with potential pathogenic activity. Because many of these proteins are involved in cancer and neurodegenerative promoting pathways, Hsp90 has emerged as an attractive therapeutic target in these diseases. Molecules that bind to the N-terminal nucleotide pocket of Hsp90 inhibit its activity, and consequently, disrupt client protein function. A number of these inhibitors from several chemical classes are now known, and some are already in clinical trials. This review focuses on the purine class of Hsp90 inhibitors, their discovery through rational design, and on efforts aimed towards their optimization and development into clinically viable drugs for the treatment of cancer. Their potential towards neurodegenerative diseases will also be touched upon.

SUBMITTER: Taldone T 

PROVIDER: S-EPMC4699796 | biostudies-literature | 2009

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Purine-scaffold Hsp90 inhibitors.

Taldone Tony T   Chiosis Gabriela G  

Current topics in medicinal chemistry 20090101 15

Hsp90 is a molecular chaperone with important roles in regulating the function of several proteins with potential pathogenic activity. Because many of these proteins are involved in cancer and neurodegenerative promoting pathways, Hsp90 has emerged as an attractive therapeutic target in these diseases. Molecules that bind to the N-terminal nucleotide pocket of Hsp90 inhibit its activity, and consequently, disrupt client protein function. A number of these inhibitors from several chemical classes  ...[more]

Similar Datasets

Unknown Structures of Hsp90? and Hsp90? bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity.
| S-EPMC6718336 | biostudies-literature
Transcriptomics The purine scaffold HSP90 inhibitor PU-H71 induces specific changes in gene expression in DLBCL xenografts.
2009-11-15 | GSE13401 | GEO
Unknown Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies.
| S-EPMC3021410 | biostudies-literature
Unknown Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.
| S-EPMC4518544 | biostudies-literature
Unknown Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90.
| S-EPMC7763603 | biostudies-literature
Unknown A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
| S-EPMC2805915 | biostudies-literature
Unknown A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-?B.
| S-EPMC3804723 | biostudies-literature
Unknown A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
| S-EPMC5762502 | biostudies-literature
Unknown Role of HSP90 in the Regulation of de Novo Purine Biosynthesis.
| S-EPMC6192518 | biostudies-literature
Unknown Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
| S-EPMC5493083 | biostudies-literature